YMAB Stock Y-mAbs Therapeutics (YMAB, $13.61) was a top loser this week, declining -17.47%

A.I.dvisor
at Tickeron.com
05/09/24
Loading...
YMAB - Y-mAbs Therapeutics

Loading...

Price: $13.61
Daily change: -$3.6 (-20.92%)
Daily volume: 1.6M
Weekly price change: -$2.88 (-17.47%)
Capitalization: $597.1M
Industry: Biotechnology
Y-mAbs Therapeutics (YMAB, $13.61) was a top weekly loser, falling -1 to $13.61 per share. Of the 910 stocks analyzed in the Biotechnology Industry throughout the week of May 5/1/2024 - 5/8/2024, 2024, of them (5) exhibited an Uptrend while of them (4) were in a Downtrend.
View a ticker or compare two or three
YMABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com